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ABSTRACT 
Objective. Acute liver failure (ALF) is haemodynamically characterized by a hyperdynamic circulation. The aims of 
this study were to investigate the systemic and regional haemodynamics in ALF, to measure changes in nitric oxide 
metabolites (NOx) and to evaluate whether these haemodynamic disturbances could be attenuated with albumin 
dialysis. Material and methods. Norwegian Landrace pigs (23–30 kg) were randomly allocated to groups as controls 
(sham-operation, n=8), ALF (hepatic devascularization, n=8) and ALF + albumin dialysis (n=8). Albumin dialysis was 
started 2 h after ALF induction and continued for 4 h. Systemic and regional haemodynamics were monitored. 
Creatinine clearance, nitrite/nitrate and catecholamines were measured. A repeated measures ANOVA was used to 
analyse the data. Results. In the ALF group, the cardiac index increased (PGT<0.0001), while mean arterial pressure 
(PG=0.02) and systemic vascular resistance decreased (PGT<0.0001). Renal resistance (PG=0.04) and hind-leg 
resistance (PGT=0.003) decreased in ALF. There was no difference in jejunal blood flow between the groups. ALF 
pigs developed renal dysfunction with increased serum creatinine (PGT=0.002) and decreased creatinine clearance 
(P=0.02). Catecholamines were significantly higher in ALF, but NOx levels were not different. Albumin dialysis did 
not attenuate these haemodynamic or renal disturbances. Conclusions. The haemodynamic disturbances during the 
early phase of ALF are characterized by progressive systemic vasodilatation with no associated changes in 
metabolites of NO. Renal vascular resistance decreased and renal dysfunction developed independently of changes in 
renal blood flow. After 4 h of albumin dialysis there was no attenuation of the haemodynamic or renal disturbances. 
Keywords: Albumin dialysis, artificial organs, hepatorenal syndrome, hyperdynamic circulation 
INTRODUCTION 
Acute liver failure (ALF) is haemodynamically characterized by hyperdynamic circulation with high cardiac output, 
low mean arterial pressure (MAP) and low systemic vascular resistance (SVR) [1], [2]. This reduction in MAP often 
requires inotropic intervention, which is a bad prognostic sign. These circulatory disturbances are thought to 
underlie the development of renal dysfunction, and a proportion of patients with ALF will become dependent upon 
some form of renal support. These derangements are reversible with liver transplantation, suggesting that they are 
consequent upon liver dysfunction. The pathophysiologic mechanisms underlying these disturbances are unclear but 
increased nitric oxide (NO) production and cGMP has been demonstrated during the later stages of the disease [1], 
[3]. There are no studies that have systematically studied the haemodynamic and renal disturbances during the early 
Ytrebø, L.M. et al., 2006. Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis. 
Scandinavian journal of gastroenterology, 41(11), p.1350–1360. 
The final publication is available at http://dx.doi.org/10.1080/00365520600714527 
phase of ALF. Accordingly, this study was undertaken to explore the circulatory disturbances during the first 6 h 
after ALF induction. 
The molecular adsorbents recirculating system (MARS) is an albumin dialysis system that is capable of removing 
protein-bound substances from the circulation [4–7]. This system has formerly been shown to improve systemic 
haemodynamic variables in patients with hyperacute liver failure and also in patients with cirrhosis [8], [9]. 
Furthermore, preliminary data suggest that MARS may be of benefit in improving renal function in patients with 
advanced cirrhosis and type I hepatorenal syndrome [10]. The mechanisms by which MARS achieves these beneficial 
effects on haemodynamic and renal function in cirrhosis are not clear but are thought to be through a reduction in 
NO levels [11]. 
We have previously described a large animal (porcine) model of ALF, induced by hepatic devascularization, which is 
associated with typical clinical and biochemical features of ALF [12–15]. The animals have a sharp increase in 
bilirubin, aminotransferases, prothrombin time and progressive reduction in MAP and SVR, with renal dysfunction 
and intracranial hypertension. The aims of the present study were to find answers to three questions relating to the 
early phase of haemodynamic disturbances in ALF: 1) Is the progressive reduction in SVR and MAP due to a 
generalized vasodilation or limited to the splanchnic region only? 2) Is this hyperdynamic circulation associated with 
an increase in the metabolites of NO and associated neurohumoral activation? 3) Can albumin dialysis attenuate the 
development of these haemodynamic and renal disturbances? 
MATERIAL AND METHODS 
Study outline 
The Norwegian Experimental Animal Board approved the present study. Twenty-four female Norwegian Landrace 
pigs (23–30 kg) were randomly allocated into three groups by opening sealed, pre-numbered envelopes: Sham, ALF 
or ALF + albumin dialysis groups. T = 0 h was defined as the time of hepatic artery ligation (ALF) or completion of 
abdominal surgery (sham). Albumin dialysis was started 2 h after hepatic devascularization and continued for 4 h, 
after which the experiments were terminated by administering an overdose of pentobarbital and potassium chloride. 
Animal preparation 
The pigs were kept in the animal department for 2 days before the experiments. Details regarding the animal room 
facilities, anaesthesia and surgical preparation have been reported previously [12–14]. ALF was induced by an end-
to-side portacaval shunt, along with ligation of the hepatic arteries. The abdomen was closed after completion of the 
surgical procedures. All animals received 500 ml 0.9% NaCl containing 625 mg glucose as a preoperative load. 
During the experiment, 0.9% NaCl was infused at a rate of 3 ml/kg/h. After ALF induction, 50% glucose and 20% 
human albumin (Octapharm, Hurdal, Norway) were continuously infused at rates of 0.6048 ml/kg/h and 0.66 
ml/kg/h, respectively. However, sham-operated animals received only half the amount of glucose (0.3024 ml/kg/h) 
in order to render the glucose levels comparable between the groups. 
For ethical reasons it would not have been possible to carry out our study without a differentiated anaesthesia 
protocol. Sham-operated animals received continuous anaesthesia during the experimental period. Anaesthesia was 
stopped after the liver was devascularized, but ALF pigs received fentanyl and midazolam if there were clinical signs 
of light sedation after completion of the liver devascularization procedure. Furthermore, the M-MARS-treated 
animals needed higher doses than the ALF group because of the removal of these substances by the M-MARS device 
[4]. Accordingly, administration of anaesthesia in the ALF groups was performed under close clinical monitoring, in 
order to keep the animals sedated and free of pain during the experimental period. All animals received equal 
amounts of intravenous fluids during the experiments. Further details regarding anaesthesia and ventilator settings 
have recently been reported [4]. Briefly, the pigs underwent a tracheotomy, and were intubated and ventilated 
(FiO2=0.5) on a volume-controlled respirator (Servo 900; Elema-Schönander, Stockholm, Sweden). Tidal volume 
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was adjusted by means of repeated arterial blood gas analyses to maintain PaCO2 levels at between 4.5 and 5.0 kPa 
during surgery. Ventilation was not altered after t = 0 h. Core body temperature was maintained normothermic at 
38.5±1°C with a heating pad and blankets (normal temperature for pigs). 
Positioning of catheters and measurements 
A 5-French Edwards Swan-Ganz catheter (Baxter Healthcare Corp., Irvine, Calif., USA) was floated into the 
pulmonary artery via the right external jugular vein. Cardiac output was measured in triplicate and the results 
expressed as the mean value (Vigilance; Edwards Lifesciences, Irvine, Calif., USA). 
A 16-G central venous catheter (Secalon T; Ohmeda, Swindon, UK) was inserted into the left external jugular vein for 
administration of drugs and fluids. We used a primed, continuous infusion of para-aminohippuric acid (PAH) 
(A1422; Sigma Chemical Co., St. Louis, Mo., USA) to measure renal plasma flow at t = 0 h and t = 6 h. MAP was 
measured in the abdominal aorta through a direct puncture catheter [16], [17]. Arterial blood samples were drawn 
from another thin catheter in the abdominal aorta. Albumin dialysis was performed through an 11.5 Fr dual lumen 
catheter (Mahurkar; Tyco Healthcare, UK) inserted in the inferior vena cava. Similar catheters were inserted in the 
shams and ALF animals as well. The urinary bladder was drained via a cystotomy. 
Renal and jejunal blood flow were determined using the fluorescent microsphere method [18]. Iliac artery blood 
flow, portal vein blood flow and portacaval shunt blood flow were continuously measured with perivascular flow 
probes (CardioMed Systems, Medistim A/S, Oslo, Norway). 
Biochemical analyses 
Arterial and venous blood samples were drawn into vacutainers (4 ml) at t = 0 h, t = 2 h, t = 4 h and t = 6 h. Samples 
were placed on ice and centrifuged at 4°C at 8500g for 5 min, and subsequently frozen at −80°C for later analyses. 
PAH was determined spectrophotometrically after deacetylation of the supernatant fluid at 100°C for 45 min[19]. 
Noradrenaline and adrenaline concentrations in urine were measured as previously described [20]. Nitrite and 
nitrate (NOx) were determined by a modified Greiss test [21]. The NOx in the filtrate was determined utilizing 
methods described by Miranda et al. [22]. Nitrite was determined using a chemiluminescence apparatus (Sievers 280 
NOA, Boulder, Colo., USA) according to established techniques [23]. 
Sodium, potassium, creatinine and urine osmolality were analysed using routine methods at the Department of 
Clinical Chemistry. 
Use of modified MARS (M-MARS) 
MARS (Teraklin AG, Rostock, Germany) (Figure 1) is an extracorporeal system utilizing a hollow fibre dialysis 
module to dialyse blood across an albumin-impregnated polysulphone membrane (cut-off 50 kDa) against 20% 
albumin as dialysate in the extra-capillary compartment [7], [24], [25]. As the present study was designed 
specifically to evaluate the role of albumin dialysis in ALF, haemofiltration/dialysis was not performed (i.e. no 
removal of free water or water-soluble toxins), and the relevant parts of the circuit were clamped off and hence 
referred to as modified-MARS (M-MARS) [4]. 
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Figure 1.  The modified molecular adsorbent recirculating system (M-MARS) set-up. Haemofiltration/haemodialysis 
unit clamped off. M1, M2, M3 and M4 indicate the sampling sites from which the dialysate samples were drawn for 
creatinine measurements at t = 6 h. 
Calculations 
Renal and jejunal blood flow (Q, ml min−1 g−1) were calculated as:  
where Qref is the withdrawal speed of the arterial reference sample (in ml/min), Ii and Iref are the fluorescence 
intensities in sample i and the reference sample, respectively, and Gi is the weight of the tissue sample. 
Renal plasma flow (ml min−1 kg body-weight−1) was calculated as:  
Renal vascular resistance, renal perfusion pressure, pulmonary vascular resistance, systemic vascular resistance 
index and vascular resistance across the hind leg were calculated in accordance with standard formulas. Body-
weight was used to calculate all indexes. 
Creatinine clearance was calculated by using the standard clearance equation:  
where x denotes creatinine. 
Fractional sodium excretion was calculated as:  
where u-Na and s-Na are the sodium concentrations in urine and serum, respectively. S-Cr and u-Cr denote the 
concentrations of creatinine in serum and urine, respectively. Plasma osmolality was calculated from the serum 
levels of the following osmoles:  
Statistical analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences, version 12.0 for Windows 
(SPSS, Chicago, Ill., USA). Data are expressed as mean values and SEM. Distributions of data were examined before 
applying parametric statistics. Two-way ANOVA was applied to test for differences within and between groups over 
time. An overall significance in analyses of variance for repeated measurements (F-test p≤0.05) may be attributable 
to either the effect of group (PG) or the interaction for group and time (PGT). Overall significance for the effect of 
group means that the groups were different when all the repeated measurements were taken together (irrespective 
of time), while a significant interaction denotes a different time course in the two groups. PT≤0.05 denotes a 
significant change during the experimental period, but without any difference between the groups. Greenhouse-
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Geisser epsilon factor adjusted probability levels were always used when Mauchly's test was significant. A p-
value ≤ 0.05 was considered significant for all tests applied. 
RESULTS  
Two pigs (one sham and one ALF) were excluded from the statistical analysis owing to localized intracranial 
haemorrhage found at post-mortem. No other complications were noted at post-mortem examination in any of the 
other pigs. 
Systemic and regional haemodynamics 
ALF versus sham. Pigs with ALF developed a hyperdynamic circulation. Cardiac index increased (PGT<0.0001), while 
MAP (PG=0.02) and SVRI decreased significantly (PGT<0.0001) (Figure 2, Figure 3A, Table I). 
 
 
 
 
 
 
  
 
Figure 2.  Mean arterial pressure (MAP) decreased in pigs with acute liver failure (ALF) and was significantly lower 
compared with that in shams (PG=0.02). Albumin dialysis did not attenuate this derangement. Mean±SEM. 
 
 
Hind-leg blood flow (Table I) did not change in the ALF group, while it initially decreased and remained lower in the 
sham group (PG=0.03). Vascular resistance across the hind leg increased in shams, whereas it decreased slightly in 
ALF (PGT<0.003) (Figure 3C). No difference was found in renal blood flow between ALF and sham animals 
(PG=0.44), nor was there any difference in renal plasma flow (Figure 6) between ALF and sham animals (PGT=0.31). 
Renal perfusion pressure dropped to 56±4 mmHg in ALF pigs compared to 80±3 mmHg in the sham group 
(PGT=0.02). Renal vascular resistance increased in shams, while it remained unchanged in the ALF group 
(PGT=0.04) (Figure 3B). There was no difference in jejunal blood flow between the sham and ALF groups after 6 h 
(p=0.56) (Figure 4). Hb decreased significantly during the course of the study in the ALF (8.2±0.2 to 6.4±0.3 g/dl) 
and ALF + M-MARS (8.5±0.2 to 6.1±0.4 g/dl) groups (p<0.01, respectively), while this decrease did not reach 
significance in sham-operated animals (8.2±0.4 to 7.6±0.2 g/dl). 
ALF + M-MARS versus ALF. Albumin dialysis did not alter any of the systemic or regional haemodynamic variables 
measured. 
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Figure 3.  Systemic vascular resistance decreased significantly (PGT<0.0001) in acute liver failure (ALF) compared 
to shams. Albumin dialysis did not attenuate this derangement. Mean±SEM. Renal vascular resistance increased in 
shams, while it remained unchanged in the ALF group (PGT=0.04). Albumin dialysis did not attenuate this 
derangement. Mean ±SEM. Vascular resistance across the hind leg increased in shams, while it slightly decreased in 
ALF (PGT=0.003). Albumin dialysis did not attenuate this derangement. Mean±SEM. 
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Table I.  Systemic and regional haemodynamic data. 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.  No difference in jejunal blood flow between the groups at t = 6 h. Mean±SEM. 
Renal function 
ALF versus sham. Serum creatinine (Table IV) increased (PGT=0.002) and creatinine clearance (p=0.02) decreased 
(Figure 5) in the ALF group. Urine output was not significantly different between the groups. 
 
 
 
 
 
  
 
Figure 5.  Creatinine clearance decreased in pigs with acute liver failure (ALF) and was significantly lower in the 
time period t = 4–6 h (p=0.02). Albumin dialysis did not improve renal function in this model. Mean±SEM. 
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Figure 6.  No difference in renal plasma flow between the acute liver failure (ALF) and sham groups during the 
experimental period (PGT=0.31). Albumin dialysis did not alter renal plasma flow. Mean±SEM. 
 
Urinary sodium excretion decreased in both groups (p=0.02) without any difference between groups. Fractional 
sodium excretion (FeNa) decreased in both groups during the experimental period, but the groups were not 
different. Serum potassium was increased in ALF animals (data not shown), which we found was correlated to 
increased potassium excretion in ALF pigs compared to shams (PG=0.04). Urine osmolality increased in shams, but 
remained unchanged in the ALF animals (PGT=0.02) (Table II). However, osmolar excretion was not different at any 
time-point. 
Table II.  Urinary excretions of adrenaline and noradrenaline were significantly higher in the ALF group compared 
to the sham group. The albumin dialysis group did not differ from the ALF group. 
 
 
 
 
 
 
 
ALF + M-MARS versus ALF. Serum creatinine decreased in the ALF + M-MARS group (PGT<0.0001). Creatinine 
clearance decreased in the ALF + M-MARS group and was not different from the ALF group at t = 6 h (Figure 5). 
However, creatinine was measured in the M-MARS circuit as well and the results show that the M-MARS system took 
off creatinine from the systemic circulation. Creatinine levels in the various segments of the M-MARS circuit at t = 6 h 
are depicted in Figure 1. 
No difference was found in urine output from ALF pigs at any time-point. Assessment of tubular function (sodium 
excretion, fractional sodium excretion) and the ability of the kidneys to concentrate urine did not reveal any 
difference between the groups (Table IV). 
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NO and catecholamines 
Noradrenaline and adrenaline excretions in urine (Table II) were significantly higher in the ALF group compared 
with the sham group (PG=0.003 and PG<0.0001, respectively). No difference was found in NOx and NO2 
concentrations (Table III) between the sham and ALF groups or between the ALF and ALF + M-MARS groups at t = 6 h. 
Table III.  Arterial plasma levels of NOx (nitrate and nitrite) and NO2 (nitrite). No significant differences between 
sham and ALF at t = 6 h. 
 
 
 
 
 
 
Table IV.  Renal function variables. Albumin dialysis group did not differ from the ALF group. 
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DISCUSSION 
In this porcine model of ALF, our results reflect typical cardiovascular features of ALF characterized by a progressive 
reduction in MAP and SVRI. However, this vasodilation was not limited to the splanchnic area, as the kidneys and 
hind-leg muscles were also affected. We also demonstrated evidence of renal dysfunction in this model, which 
occurred independently of changes in renal blood flow. Furthermore, we showed that this generalized vasodilation 
with consequent reduction in MAP was associated with activation of the neurohumoral system, indicated by an 
increase in the catecholamines but not with any significant changes in nitrates or nitrites. Finally, 4 h of therapy with 
MARS did not attenuate these circulatory and renal disturbances. 
The data from the present study confirm those from our previous observations of significant haemodynamic 
disturbances in ALF characterized by increased cardiac output and decreased MAP and SVRI [12], [14]. The most 
important observation in our study was that we found a reduction in the vascular resistance of the kidneys and hind 
leg, which accompanied the reduction in SVRI. Furthermore, there was no difference in jejunal blood flow between 
the sham and ALF groups at t = 6 h. Although we were unable to calculate vascular resistance across the gut, jejunal 
blood flow and MAP data are suggestive of a significant reduction of vascular resistance across the jejunum in ALF 
compared with sham-operated controls. Taken together, this is in contrast to that observed in cirrhosis and suggests 
that extrapolation of pathophysiologic mechanisms and therapy from cirrhosis to ALF is unlikely to be correct. 
However, this observation suggesting that there is no splanchnic vasodilation in ALF must be viewed with some 
caution as we describe changes in jejunal blood flow using the microsphere technique in a model where ALF has 
been induced by the surgical procedure, portacaval shunting. 
Activation of the neurohumoral system is likely to represent a compensatory response to the observed vasodilation. 
Decreased effective circulatory volume is also known to activate the neurohumoral system, which results in 
increased catecholamine levels. However, the mechanisms of this “generalized” systemic vasodilation remain 
unclear. There is substantial evidence in cirrhosis to show that NO is important and increased cGMP has been 
observed in ALF [1], [3]. The lack of any significant change in metabolites of NO during the development of these 
circulatory abnormalities support the view that NO is not an important initiating mechanism in the development of 
the hyperdynamic circulation in ALF. However, before we can dismiss the NO hypothesis as an initiating factor for 
the observed haemodynamic disturbances, further studies involving measurement of the rate of NO production and 
use of specific NO inhibitors are necessary. 
To date, renal dysfunction in ALF has been thought to be associated with severe renal vasoconstriction and 
significant reduction in renal blood flow [26–28]. This notion has been attributed to two experimental studies [27], 
[28]. These studies were performed in a galactosamine rat model, in which decreased renal blood flow and increased 
renal vascular resistance were demonstrated 48 h after ALF induction. Although there were signs of decreased renal 
function before t = 48 h, decreased creatinine clearance was only discussed in relation to the findings of increased 
renal vascular resistance and decreased renal blood flow. The seemingly contradictory results between our 
observations and those reported previously may relate to the timing of the measurements, the use of resuscitation 
and the type of model used. Our studies explored an early phase of renal dysfunction following ALF induction, while 
the other studies focused on renal haemodynamics and function at a later stage. An alternative explanation is the 
potential effect of resuscitation. Our animals were resuscitated, while the rats in the other two studies were not. This 
fact might explain the differences in systemic and regional haemodynamics. Finally, in the previous studies, ALF was 
induced by galactosamine, which is known to induce bacterial translocation, portal endotoxaemia and significant 
portosystemic shunting [27], [29], [30]. Accordingly, the circulatory derangements observed in galactosamine-
induced ALF models are likely to be different from devascularized ALF models. In the present study there was no 
evidence of inflammation [31]. This discrepancy between the models is important and might have contributed 
significantly to the differences observed. If our observations are put in the context of the data in the literature, it is 
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possible that these studies describe two different stages of the disease; generalized vasodilation in the initial stage 
and vasoconstriction of the regional vascular beds in the later stages possibly due to the effect of activation of the 
neurohormonal system. This hypothesis will need to be tested in future studies. 
Furthermore, our data indicate that the pathophysiological basis of renal dysfunction in this model of ALF is different 
from hepatorenal syndrome (HRS) seen in patients with chronic liver failure. We found a significant reduction in 
creatinine clearance indicating a reduction in glomerular filtration rate (GFR), despite no change in renal plasma 
flow (RPF). There was no biochemical evidence of an acute tubular dysfunction in pigs with ALF. Although the urine 
osmolality was lower, osmolal excretion was not significantly different from shams, owing to differences in urine 
output. As GFR is the product of RPF and the filtration fraction, a decrease in GFR must have been caused by a 
decreased glomerular filtration fraction. Filtration fraction is determined by the filtration coefficient and glomerular 
filtration pressure [32]. Unfortunately, our data did not allow us to explore these mechanisms in greater detail. 
The results of our study showing no significant effects of M-MARS on the systemic haemodynamics and renal 
function are at variance with the previous observations in patients with ALF. In an open, non-randomized study of 
eight patients with hyperacute ALF caused by paracetamol intoxication or hepatitis B infection [9], MARS was found 
to increase MAP and decrease CI. However, the improvement in systemic haemodynamics with MARS is not a 
universal phenomenon, and in a recently published study on patients with acute-on-chronic liver failure, we were 
not able to observe any significant improvements in systemic haemodynamics or renal function with MARS [11]. It is 
possible that the lack of any observed effect of MARS on the systemic haemodynamic variables in the present study 
may be related to the relatively short duration of treatment. Although the present model is associated with typical 
clinical and biochemical features of ALF [12–15], liver ischaemia is not a common aetiology for ALF [33], [34] and the 
animals were studied within a rather short time frame. These facts should be borne in mind when data are 
interpreted. 
In summary, the results of this study show that the progressive systemic vasodilation in ALF is generalized and not 
limited to the splanchnic area and that these haemodynamic changes are not accompanied by an increase in NO 
metabolites. The renal dysfunction of ALF is an early phenomenon and occurs independently of changes in RPF and 
is probably due to alternations in GFR. Future studies should address the factors initiating the vascular and renal 
disturbances in ALF. 
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